SCHEMBL8285252

SCHEMBL8285252

Cc1cc(-c2cccc([N+](=O)[O-])c2)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.46
ABCC1 P33527 2/20 0.46
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
CSNK2A1 P68400 1/20 0.42
GAA P10253 4/20 0.42
MAPT P10636 4/20 0.42
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 2/20 0.42
GSK3B P49841 1/20 0.41
LMNA P02545 3/20 0.41
HTT P42858 2/20 0.41
ABCB1 P08183 1/20 0.41
PDE11A Q9HCR9 1/20 0.41
NPC1 O15118 1/20 0.40
XBP1 P17861 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286417 0.83 ABCG2 (0.46) ABCG2ABCC1MEN1KMT2ACSNK2A1
SCHEMBL8285206 0.81 PDE11A (0.43) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL8285163 0.78 POLB (0.50) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL8285238 0.77 PDE11A (0.49) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL5871846 0.77 PDE11A (0.49) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL8287832 0.76 PDE11A (0.47) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL8287154 0.76 PDE11A (0.48) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL8286440 0.76 PDE11A (0.48) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL8287830 0.75 PDE11A (0.48) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL8286186 0.74 LMNA (0.41) ABCG2ABCC1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed